Exelixis (NasdaqGS:EXEL) recently announced positive topline results from the STELLAR-303 Phase 3 trial, highlighting the ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Too many people are missing out on a potentially life-changing opportunity to prevent cancer,” said Sir John Burn.

According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and ...

Bobbi Conner talks with MUSC's Dr. Thomas Curran about the latest research showing that a structured exercise program extends ...

Weight-loss surgery seems to lower the risk of colorectal cancer by changing where bile acids enter the small intestine, ...

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Positive results in patients with advanced mCRC emphasize potential significance of CytoDyn’s ongoing Phase II CRC trial Dr. Benjamin Weinberg to present final results at the ESMO Gastrointestinal ...

SpotitEarly’s at-home breath test pairs canine scent detection with AI to deliver non-invasive, affordable early cancer ...

Curcumin contained in turmeric, the main ingredient of curry, can suppress the early onset of colorectal cancer, according to ...